TETRAPHASE PHARMACEUTICALS INC Deferred Revenue
TETRAPHASE PHARMACEUTICALS INC had Deferred Revenue of $109.00 thousand as of 2018-06-30, per its 10-Q filed 2018-08-02.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current › Deferred Revenue, Current
us-gaap:DeferredRevenueCurrent · last filed 2018-08-02
- 2018-06-30: Deferred Revenue, Current $109.00K.
- 2018-03-31: Deferred Revenue, Current $7.48M.
- 2017-12-31: Deferred Revenue, Current $660.00K.
- 2017-09-30: Deferred Revenue, Current $782.00K.
| Period end | Deferred Revenue, Current |
|---|---|
| 2018-06-30 | $109.00K 10-Q · filed 2018-08-02 |
| 2018-03-31 | $7.48M 10-Q · filed 2018-05-03 |
| 2017-12-31 | $660.00K 10-Q · filed 2018-08-02 |
| 2017-09-30 | $782.00K 10-Q · filed 2017-11-01 |
| 2017-06-30 | $1.55M 10-Q · filed 2017-08-02 |
| 2017-03-31 | $851.00K 10-Q · filed 2017-05-08 |
| 2016-12-31 | $1.25M 10-K · filed 2018-03-06 |
| 2016-09-30 | $1.08M 10-Q · filed 2016-11-03 |
| 2016-06-30 | $1.20M 10-Q · filed 2016-08-04 |
| 2016-03-31 | $1.38M 10-Q · filed 2016-05-04 |
| 2015-12-31 | $909.00K 10-K · filed 2017-03-13 |
| 2015-09-30 | $385.00K 10-Q · filed 2015-11-02 |
| 2015-06-30 | $524.00K 10-Q · filed 2015-08-06 |
| 2015-03-31 | $1.02M 10-Q · filed 2015-05-07 |
| 2014-12-31 | $258.00K 10-K · filed 2016-02-25 |
| 2014-09-30 | $24.00K 10-Q · filed 2014-11-10 |
| 2013-12-31 | $92.00K 10-K · filed 2015-03-06 |
| 2013-09-30 | $242.00K 10-Q · filed 2013-11-14 |
| 2013-03-31 | $333.00K 10-Q · filed 2013-05-13 |
| 2012-12-31 | $699.00K 10-K · filed 2014-03-06 |